Semisynthetic Flavonoids as GSK-3β Inhibitors: Computational Methods and Enzymatic Assay
Targets · 15.04.2025 · 3 (2) · 13
DOI: 10.3390/targets3020013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targets, online erschienen am 15.04.2025. Verfasst von Heberth de Paula und 8 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian Coordination for the Improvement of Higher Education Personnel, National Council for Scientific and Technological Development (CNPq), Espírito Santo Research and Innovation Support Foundation.
Abstract (Originalsprache)
Glycogen synthase kinase-3 beta (GSK-3β) plays a crucial role in multiple cellular processes and is implicated in different types of cancers and neurological disorders, including Alzheimer’s disease. Despite extensive efforts to develop novel GSK-3β inhibitors, the discovery of potent and selective lead compounds remains a challenge. In this study, we evaluated the GSK-3β inhibitory potential of semisynthetic flavonoid derivatives, which exhibited sub-micromolar activity. To gain further insights, we employed molecular docking, molecular dynamics simulations, and pharmacokinetic profile predictions. The docking studies revealed that the most potent inhibitor, compound 10, establishes key interactions with the ATP-binding site. Molecular dynamics simulations further confirmed that compound 10 maintains stable interactions with GSK-3β throughout the simulation. Additionally, pharmacokinetic predictions identified compound 3 as a promising candidate for Alzheimer’s disease therapy due to its ability to cross the blood–brain barrier. These findings suggest that, within the studied flavonoid derivatives, these compounds (particularly 10 and 3) hold potential as lead compounds for GSK-3β inhibition. The combination of strong enzymatic inhibition, stable binding interactions, and favorable pharmacokinetic properties highlights their promise for further development in cancer and neurodegenerative disease research.
Förderung
- Brazilian Coordination for the Improvement of Higher Education Personnel
- National Council for Scientific and Technological Development (CNPq)
- Espírito Santo Research and Innovation Support Foundation
- INCTBioNat
- NCQP-UFES
- University of Warwick
Zitieren
APA
Paula, H. D., Souza, F., Ferreira, L., Silva, J. A. B., Ribeiro, R., Vilachã, J., Emery, F. S., Lacerda, V., & Morais, P. A. B. (2025). Semisynthetic Flavonoids as GSK-3β Inhibitors: Computational Methods and Enzymatic Assay. Targets, 3(2), 13. https://doi.org/10.3390/targets3020013
Vancouver
Paula HD, Souza F, Ferreira L, Silva JAB, Ribeiro R, Vilachã J, et al. Semisynthetic Flavonoids as GSK-3β Inhibitors: Computational Methods and Enzymatic Assay. Targets. 2025;3(2):13. doi:10.3390/targets3020013
BibTeX
@article{Paula2025,
author = {Paula, Heberth de and Souza, Fernanda and Ferreira, Lara and Silva, Jéssica A. B. and Ribeiro, Rayssa and Vilachã, Juliana and Emery, Flávio S. and Lacerda, Valdemar and Morais, Pedro A. B.},
title = {Semisynthetic Flavonoids as GSK-3β Inhibitors: Computational Methods and Enzymatic Assay},
journal = {Targets},
year = {2025},
volume = {3},
number = {2},
pages = {13},
doi = {10.3390/targets3020013}
}
EUVIMED